Clinical Trials in Xinjiang, China
6 recruiting
Showing 1–12 of 12 trials
Recruiting
Phase 2
A Study to Evaluate the Efficacy and Safety of ICP-248 in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (APEX-06)
Relapsed or Refractory Mantle Cell Lymphoma (MCL)
Beijing InnoCare Pharma Tech Co., Ltd.75 enrolled29 locationsNCT07082686
Recruiting
Phase 2
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
Obstructive Hypertrophic Cardiomyopathy (oHCM)
China National Center for Cardiovascular Diseases44 enrolled3 locationsNCT07367724
Recruiting
Phase 3
The Efficacy and Safety of Inpegsomatropin Injection in Children With Idiopathic Short Stature
Idiopathic Short Stature
Xiamen Amoytop Biotech Co., Ltd.300 enrolled38 locationsNCT06927310
Recruiting
Phase 2
Evaluating the Preliminary Efficacy and Safety of JS207 in NSCLC After Progression Following Platinum-based Chemotherapy and Immunotherapy
Advanced NSCLC
Shanghai Junshi Bioscience Co., Ltd.66 enrolled18 locationsNCT06924606
Recruiting
Phase 1Phase 2
Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
Herpes ZostermRNA Vaccine
Sinovac Biotech Co., Ltd519 enrolled1 locationNCT07400003
Recruiting
Not Applicable
LISH Trial for the Hepatic Flexure and Proximal Transverse Colon Cancer
Hepatic Flexure Colon CancerProximal Transverse Colon Cancer
Zhejiang University568 enrolled29 locationsNCT05923255
Recruiting
Phase 2
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
TNBC - Triple-Negative Breast Cancer
First Affiliated Hospital of Zhejiang University35 enrolled13 locationsNCT06682195
Recruiting
Phase 2
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer
Ovarian CancerEndometrial CancerPrimary Peritoneal Cancer+1 more
Hansoh BioMedical R&D Company460 enrolled28 locationsNCT06014190
Recruiting
Phase 2
ARTEMIS-006: HS-20093 in Patients With Head and Neck Squamous Cell Carcinoma and Other Solid Tumors
Head and Neck Squamous Cell Carcinoma
Hansoh BioMedical R&D Company170 enrolled25 locationsNCT06007729
Recruiting
Phase 3
A Phase 3b Randomized, Double-blind, Multi-center Study to Compare the Safety and Efficacy of Omadacycline to Moxifloxacin for Treating Adult Subjects With CABP
Community-acquired Bacterial Pneumonia
Zai Lab (Hong Kong), Ltd.100 enrolled40 locationsNCT06162286
Recruiting
Chinese Psoriasis Real World Evidence Research
Psoriasis
Second Affiliated Hospital, School of Medicine, Zhejiang University10,000 enrolled29 locationsNCT04465838
Recruiting
Phase 3
Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University688 enrolled17 locationsNCT02062489